Salutem Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 26-12-2024
- Paid Up Capital ₹ 0.10 M
as on 26-12-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -8.97%
(FY 2020)
- Profit 86.41%
(FY 2020)
- Ebitda 79.97%
(FY 2020)
- Net Worth 16409.67%
(FY 2020)
- Total Assets 79.97%
(FY 2020)
About Salutem Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sahil Mahajan and Mandeep Bhamra serve as directors at the Company.
- CIN/LLPIN
U24290JK2016PTC009772
- Company No.
009772
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jammu
Industry
Company Details
- Location
Jammu, Jammu & Kashmir, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Salutem Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sahil Mahajan  | Director | 13-Oct-2016 | Current |
| Mandeep Bhamra | Director | 17-Jul-2021 | Current |
Financial Performance of Salutem Pharmaceuticals.
Salutem Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 8.97% decrease. The company also saw a substantial improvement in profitability, with a 86.41% increase in profit. The company's net worth Soared by an impressive increase of 16409.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Salutem Pharmaceuticals?
In 2018, Salutem Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ravenbhel Health Care Private LimitedActive 21 years 9 monthsSahil Mahajan and Mandeep Bhamra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Salutem Pharmaceuticals?
Unlock and access historical data on people associated with Salutem Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Salutem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Salutem Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
